期刊文献+

卵巢浆液性癌组织中起始因子EIF5A2和基质金属蛋白酶-21的表达及临床意义 被引量:5

Expression and significance of EIF5A2 and MMP-21 in ovarian serous carcinoma
下载PDF
导出
摘要 目的:检测真核翻译起始因子5A2(EIF5A2)和基质金属蛋白酶-21(MMP-21)在卵巢浆液性癌组织中的表达,分析其临床意义,关注两者与增殖指标的关系。方法:选择79例卵巢浆液性癌作为观察组,选择79例卵巢浆液性囊腺瘤作为对照组,留取术后新鲜组织和石蜡包埋组织。应用免疫组化检测两组石蜡包埋组织中EIF5A2、MMP-21的表达,应用Western Blot法检测观察组中增殖细胞核抗原(PCNA)的表达。结果:两组中EIF5A2和MMP-21的表达差别有统计学意义,观察组中EIF5A2和MMP-21的表达在不同脉管累犯、淋巴结转移及肿瘤最大径的分组中差别有统计学意义,在不同年龄、病理分级、神经累犯的分组中无明显差别。EIF5A2和MMP-21、EIF5A2和PCNA、MMP-21和PCNA均具有正相关性。EIF5A2和MMP-21的表达与生存时间有关。结论:EIF5A2和MMP-21高表达且具有正相关性是卵巢浆液性癌重要的分子事件,两者可能对肿瘤的增殖有一定的影响。联合检测两者的表达与患者的预后有关。 Objective:To detect the expression of eukaryotic translation initiation factor 5 A2(EIF5 A2)and matrix metalloproteinase-21(MMP-21),analyze their clinical significance,and obtain the relationship between them and proliferation indicator. Methods:79 cases of ovarian serous carcinoma were selected as the observation group and 79 cases of ovarian serous cystadenoma as the control group. The fresh tissues and paraffin embedded tissues were collected after operation. The expression of EIF5 A2 and MMP-21 in paraffin embedded tissues of the two groups were detected by immunohistochemistry,and PCNA in the observation group was detected by Western blot. Results:The expression of EIF5 A2 and MMP-21 in two groups were statistically different. The expression of EIF5 A2 and MMP-21 in the observation group were statistically different in vascular involvement,lymph node metastasis and maximum tumor size,but there was no statistically different in age,pathological grade and neural involvement. Positive correlation was found between EIF5 A2 and MMP-21,EIF5 A2 and PCNA,MMP-21 and PCNA. The expression of EIF5 A2 and MMP-21 were correlated with survival time. Conclusion:High expression and positive correlation of EIF5 A2 and MMP-21 are important molecular events in ovarian serous carcinoma. EIF5 A2 and MMP-21 may have some influence on the proliferation of the tumor. The combined detection of their expression is related to the prognosis of patients.
作者 王莉 WANG Li(Department of Gynecology,the First Affiliated Hospital of Jinzhou Medical University,Jinzhou 121000)
出处 《陕西医学杂志》 CAS 2020年第4期411-414,共4页 Shaanxi Medical Journal
基金 辽宁省自然科学基金资助项目(20180551184)。
关键词 卵巢浆液性癌 真核翻译起始因子5A 2 基质金属蛋白酶-21 增殖 预后 Ovarian serous carcinoma EIF5A 2 MMP-21 Proliferation Prognosis
  • 相关文献

参考文献6

二级参考文献48

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8240
  • 2Ibrahim FF, Jamal R, Syafruddin SE, et al. MicroRNA- 200c and microRNA-31 regulate proliferation, colony for- mation, migration and invasion in serous ovarian cancer [J]. J Ovarian Res, 2015, 8:56.
  • 3Orozco AF, Lewis DE. Flow cytometric analysis of circu- lating microparticles in plasma [J]. Cytometry A, 2010, 77(6) :502-514.
  • 4Mitchell P S,Parkin R K, Kroh E M, et al. Circulating micro RNAs as stable blood-based markers for cancer de- tection [J]. Proc Natl Acad Sci USA, 2008, 105: 10513 - 10518.
  • 5Jiang C, Chen X, Alattar M, et al. MicroRNAs in tumori- genesis, metastasis, diagnosis and prognosis of gastric cancer [J]. Cancer Gene Ther, 2015, 22(6) :291-301.
  • 6Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer [J]. Nat Rev Cancer, 2015, 15(6):321-333.
  • 7Calin CA, Croce CM. Micro RNA signatures in human cancers [J]. Nat Rev Cancer, 2006, 6:857-866.
  • 8Lu J, Gerz G, Miska EA, et al. Micro RNA expression profiles classify human cancer [J]. Nature, 2005, 435: 834-838.
  • 9Sotiopoulou G, Pampalakis G, Lianidou E, et al. Emer- ging of micro RNAs as molecular switches in the integrat ed circuit of the cancer cell[J]. RNA, 2009, 15(8) :1443- 1461.
  • 10Orozco AF, Lewis DE. Flow cytometric analysis of circu- lating micropartieles in plasma [J]. Cytometry A, 2010, 77(6) :502 -514.

共引文献48

同被引文献50

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部